269 IMPAIRED PERFORMANCE AND “PARADOXICAL” HYPERACTIVITY DURING PHENOBARBITAL ADMINISTRATION TO DEVELOPING RAT PUPS WITH EXPERIMENTAL MINIMAL BRAIN DYSFUNCTION(MBD)

B. Shaywitz,David A. Pearson
DOI: https://doi.org/10.1203/00006450-197804001-00274
IF: 3.953
1978-04-01
Pediatric Research
Abstract:Phenobarbital may produce significant behavioral alterations and cognitive deficits in children and impaired brain growth in developing animals. We have investigated the long term consequences of phenobarbital administration on activity levels and cognitive performance in normal developing rat pups and littermates receiving intracisternal injections of 6-hydroxydopamine (6-OHDA) at 5 days of age. In normal rat pups, phenobarbital reduced activity levels at 26 days of age (p < 0.05), but did not affect avoidance performance. However, in 6-OHDA rat pups phenobarbital reduced activity at 19 days (p < 0.001) increased activity at 26 days of age (p < 0.05) and significant impaired both T-maze and shuttle box performance (p < 0.001). Phenobarbital concentrations at 35 days (EMID Technique) averaged 15.5 + 2.01 and 20.2 + 2.76 μg/ml in control and 6-OHDA rat pups respectively (p > 0.05). Body weight was significantly reduced in 6-OHDA rat pups from day 8 but there were never significant differences between phenobarbital and control animals. Brain dopamine concentrations in 6-OHDA animals averaged 35.5% of littermate controls and did not differ between phenobarbital and control animals. These findings support the notion that phenobarbital administration may adversely affect activity and cognitive performance in the developing mammalian brain and suggest caution in the routine use of this agent.
What problem does this paper attempt to address?